Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Optimal Timing of Radiotherapy with Alternating/Sequential Radio-Chemotherapy for Limited-stage Small Cell Lung Cancer

  • Wang, Li-Jie (School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences) ;
  • Liu, Xiu-Ju (Department of Medical Oncology, Shandong Cancer Hospital) ;
  • Guan, Yan (Department of Medical Oncology, Shandong Cancer Hospital) ;
  • Zhang, Chu-Feng (School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences) ;
  • Wang, Peng (School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences) ;
  • Li, Yan (Department of Medical Oncology, Shandong Cancer Hospital) ;
  • Guo, Qi-Sen (Department of Medical Oncology, Shandong Cancer Hospital)
  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To investigate the optimal timing of radiotherapy with alternating/sequential radio-chemotherapy for limited-stage small cell lung cancer (LS-SCLC). Methods: 91 patients with LS-SCLC were retrospectively analyzed and divided into two groups according to the number of chemotherapy cycles before radiotherapy. If the patient received radiotherapy after 3 cycles or fewer cycles of chemotherapy, classification was into the early group, if not, into the late group. All patients received 6 cycles of standard chemotherapy (EP/EC) and conventional radiotherapy (56 gy~ 60 gy/28 f ~30 f). Results: The response rate (RR) of the early and late groups were 85.7% and 81.6%, respectively, with no significant difference (p>0.05). In contrast, the progression-free survival (PFS) in the early group was better than that in the late group (11.8 months vs 9.86 months), and the difference was significant (p<0.05). There was no significant difference between two groups in adverse reactions, which gastrointestinal irritation and bone marrow suppression being the most common (p>0.05). Conclusions: Radiotherapy after 3 cycles or fewer cycles of chemotherapy does not bring significant benefits for RR of patients with LS-SCLC, but it could significantly prolong their PFS without increase in adverse reactions.

Keywords

References

  1. Arriagada R, Pignon JP, Ihde DC, et al. (1994). Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2, 140 patients. Anticancer Res, 14, 333-5.
  2. Chen YT, Feng B, Chen LB (2012). Update of research on drug resistance in small cell lung cancer chemotherapy. Asian Pac J Cancer Prev, 13, 3577-81. https://doi.org/10.7314/APJCP.2012.13.8.3577
  3. El Sharouni SY, Kal HB, Barten-Van Rijbroek A, et al. (2009). Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study. Anticancer Res, 29, 5219-24.
  4. Pignon JP, Arriagada R, Ihde DC, et al. (1992). A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med, 327, 1618-24. https://doi.org/10.1056/NEJM199212033272302
  5. Pignon JP, Stewart LA (1996). Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a metaanalysis. Cancer, 77, 2413-4. https://doi.org/10.1002/(SICI)1097-0142(19960601)77:11<2413::AID-CNCR34>3.0.CO;2-Y
  6. Pijls-Johannesma MC, De Ruysscher D, Lambin P, et al. (2005). Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev, CD004700.
  7. Takada M, Fukuoka M, Kawahara M, et al. (2002). Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol, 20, 3054-60. https://doi.org/10.1200/JCO.2002.12.071
  8. Tsukada H, Yokoyama A, Goto K, et al. (2001). Concurrent versus sequential radiotherapy for small cell lung cancer. Semin Oncol, 28, 23-6. https://doi.org/10.1053/sonc.2001.25741
  9. Zhao H, Gu J, Hua F, et al. (2010). A meta-analysis of the timing of chest radiotherapy in patients with limited-stage small cell lung cancer. Zhongguo Fei Ai Za Zhi, 13, 892-7.

Cited by

  1. Effects of Definitive Chemoradiotherapy on Respiratory Function Tests and Quality of Life Scores During Treatment of Lung Cancer vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6779